anmelden
Neogenomics Aktie
9,57
EUR
-0,09
EUR
-0,91
%
11,13
USD
+0,74
USD
+7,12
%
Neogenomics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Neogenomics Aktie Analyse
| 01.05.19 | Neogenomics Buy | Needham & Company, LLC | |
| 29.03.19 | Neogenomics Buy | Needham & Company, LLC | |
| 03.01.19 | Neogenomics Buy | Needham & Company, LLC | |
| 24.10.18 | Neogenomics Strong Buy | First Analysis Securities | |
| 24.08.17 | Neogenomics Buy | Gabelli & Co | |
| 15.12.16 | Neogenomics Overweight | Cantor Fitzgerald | |
| 04.10.16 | Neogenomics Overweight | First Analysis Securities | |
| 28.04.16 | Neogenomics Buy | The Benchmark Company | |
|
Werbung
|
|||
| 11.03.16 | Neogenomics Buy | The Benchmark Company | |
| 26.10.15 | Neogenomics Buy | ROTH Capital Partners, LLC | |
| 13.07.15 | Neogenomics Buy | ROTH Capital Partners, LLC | |
| 07.04.09 | Neogenomics | Global Biotech Investing | |
Werbung
Werbung